Close

Akers Biosciences (AKER), MyMD Pharmaceuticals Announce Stockholder Approval of Merger

April 16, 2021 12:32 PM EDT Send to a Friend
Akers Biosciences, Inc. (“Akers”) (Nasdaq: AKER) and MyMD Pharmaceuticals, Inc. (“MYMD”) today announced that at Akers’ special meeting of stockholders ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login